Co-Diagnostics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CODX Nasdaq 3840 co-dx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Co-Diagnostics, Inc.

Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates - Nov 6th, 2025 3:20 pm
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd - Nov 5th, 2025 7:00 am
CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates - Nov 4th, 2025 4:15 pm
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform - Nov 3rd, 2025 7:00 am
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast - Oct 31st, 2025 7:00 am
Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia - Oct 30th, 2025 11:57 am
Sector Update: Health Care Stocks Fall Late Afternoon - Oct 29th, 2025 1:54 pm
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Oct 29th, 2025 10:51 am
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Oct 28th, 2025 7:33 am
Trending tickers: Amazon, Qualcomm, Tesla, Co-Diagnostics and Qorvo - Oct 28th, 2025 3:13 am
Sector Update: Health Care Stocks Softer Monday Afternoon - Oct 27th, 2025 11:48 am
BC-Most Active Stocks - Oct 27th, 2025 8:30 am
Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East - Oct 27th, 2025 6:45 am
EXCLUSIVE: Co-Diagnostics Inks JV With Saudi Arabia Firm For Middle East Market - Oct 27th, 2025 6:30 am
Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia - Oct 22nd, 2025 6:30 am
Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing - Oct 16th, 2025 7:30 am
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit - Oct 13th, 2025 7:30 am
Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30 - Sep 30th, 2025 7:30 am
Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Sep 18th, 2025 3:05 pm
Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Sep 17th, 2025 7:46 am